障害者政策総合研究事業（精神障害分野）
（○：委員長）
| 鹿島 晴雄 | 慶應義塾大学医学部 客員教授 | ||
| 精神医学 | |||
| 鹿島晴雄,加藤元一郎,本田哲三： 認知リハビリテーション. 医学書院,東京,1999.10. |
|||
| Kashima H, Faloon Ian, Mizuno M, Asai M(eds.) Comprehensive Treatment of Schizophrenia. Springer, Tokyo, 2002.1. |
|||
| 鹿島晴雄,古城慶子,古茶大樹,針間博彦,前田貴記 編著: 妄想の臨床. 新興医学出版社,東京, 2013.6. |
|||
| 神尾 陽子 | 神尾陽子クリニック 院長 | ||
| 児童精神医学 | |||
| Kamio Y, Inada N, Koyama T, Inokuchi E, Tsuchiya K, Kuroda M (2014). Effectiveness of using the Modified Checklist for Autism in Toddlers in two-stage screening of autism spectrum disorder at the 18-month health check-up in Japan. J Autism Dev Disord,44(1):194-203. | |||
| Kamio Y, Inada N, Koyama T (2013). A nationwide survey on quality of life and associated factors of adults with high-functioning autism spectrum disorders. Autism, 17(1):15-26. | |||
| Kamio Y, Inada N, Moriwaki A, Kuroda M, Koyama T, Tsujii H, Kawakubo Y, Kuwabara H, Tsuchiya KJ, Uno Y, Constantino JN (2013). Quantitative autistic traits ascertained in a national survey of 22,529 Japanese schoolchildren. Acta Psychiatrica Scandinavica, 128(1), 45-53, DOI 10.1111/acps.12034 | |||
| 川上 憲人 | 東京大学大学院医学系研究科 特任教授／一般財団法人淳風会 代表理事理事長 | ||
| 精神保健学 | |||
| Kawakami N, Sasaki N, Asaoka H, Kuroda R, Tsuno K, Imamura K. Effects of workplace measures against COVID-19 and employees' worry about them on the onset of major depressive episodes: A 13-month prospective study of full-time employees. J Affect Disord. 2023 Feb 1;322:187-193. | |||
| Imamura K, Tran TTT, Nguyen HT, Sasaki N, Kuribayashi K, Sakuraya A, Bui TM, Nguyen AQ, Nguyen QT, Nguyen NT, Nguyen KT, Nguyen GTH, Tran XTN, Truong TQ, Zhang MW, Minas H, Sekiya Y, Watanabe K, Tsutsumi A, Kawakami N. Effect of smartphone-based stress management programs on depression and anxiety of hospital nurses in Vietnam: a three-arm randomized controlled trial. Sci Rep. 2021 May 31;11(1):11353. | |||
| Kessler RC, Kazdin AE, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Altwaijri YA, Andrade LH, Benjet C, Bharat C, Borges G, Bruffaerts R, Bunting B, de Almeida JMC, Cardoso G, Chiu WT, Cía A, Ciutan M, Degenhardt L, de Girolamo G, de Jonge P, de Vries YA, Florescu S, Gureje O, Haro JM, Harris MG, Hu C, Karam AN, Karam EG, Karam G, Kawakami N, Kiejna A, Kovess-Masfety V, Lee S, Makanjuola V, McGrath JJ, Medina-Mora ME, Moskalewicz J, Navarro-Mateu F, Nierenberg AA, Nishi D, Ojagbemi A, Oladeji BD, O'Neill S, Posada-Villa J, Puac-Polanco V, Rapsey C, Ruscio AM, Sampson NA, Scott KM, Slade T, Stagnaro JC, Stein DJ, Tachimori H, Ten Have M, Torres Y, Viana MC, Vigo DV, Williams DR, Wojtyniak B, Xavier M, Zarkov Z, Ziobrowski HN; WHO World Mental Health Survey collaborators. Patterns and correlates of patient-reported helpfulness of treatment for common mental and substance use disorders in the WHO World Mental Health Surveys. World Psychiatry. 2022 Jun;21(2):272-286. | |||
| 阪上 優 | 京都大学環境安全保健機構 教授 部門長 京都大学大学院医学研究科産業厚生医学 教授 |
||
| 産業精神医学、神経科学 | |||
| Jiro Takeuchi and Yu Sakagami. Association between autistic tendencies and mental health when studying abroad. Pediatric Internaitonal．2022 January；64：e14724. |
|||
| Jiro Takeuchi and Yu Sakagami. Belief of Safety and Ethicality Associated with Agreement to Electro-Convulsive Therapy among Universities and Other Research Institution Employees. Psychiatry and Clinical Neurosciences Reports. 2022；1：e40. |
|||
| Miki Noda, Yu Sakagami, Hiroshi Tsujimoto. The psychological process of workers who access mental health services: a qualitative study focused on workers’ sense of ‘me as a worker’. Asia Pacific Journal of Counselling and Psychotherapy. 2019；10(2)：111-124. |
|||
| 曽良 一郎 | 神戸大学大学院医学研究科デジタル精神医学部門 特命教授 | ||
| 精神医学、精神神経薬理学 | |||
| Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98: 5300-5305 (2001) | |||
| Ikeda K, Ide S, Han W, Hayashida M, Uhl GR, Sora I. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 26(6): 311-317 (2005) | |||
| Arime Y, Kasahara Y, Hall FS, Uhl GR, Sora I. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology 37(11): 2522-2530 (2012) | |||
| ○ | 中込 和幸 | 国立精神・神経医療研究センター 理事長 | |
| 精神神経学・臨床精神神経薬理 | |||
| Brown D, Nakagome K, Cordes J, Brenner R, Gründer G, Keefe RSE, Riesenberg R, Walling DP, Daniels K, Wang L, McGinniss J, Sand M. Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Schizophr Bull, 45(2): 350-359, 2019. | |||
| Nakagome K, Yokoi Y, Nakagawa A, Tani M, Nishioka G, Yoshimura N, Furukawa TA, Watanabe K, Mimura M, Iwanami A, Abe T. Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial. J Affect Disord. 282: 1011-1020, 2021. | |||
| Fleischhacker WW, Podhorna J, Gröschl M, Hake S, Zhao Y, Huang S, Keefe RSE, Desch M, Brenner R, Walling DP, Mantero-Atienza E, Nakagome K, Pollentier S. Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study. Lancet Psychiatry. 8(3): 191-201, 2021. | |||
| 樋口 進 | 独立行政法人国立病院機構久里浜医療センター 院長 | ||
| 精神医学 | |||
| Higuchi S, Matsushita S, Imazeki H, Kinoshita T, Takagi S, Kono H: Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 343: 741-742, 1994. | |||
| Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M: Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 152: 1219-1221, 1995. | |||
| Higuchi S, the Japanese Acamprosate Study Group: Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double blind, placebo-controlled study conducted in Japan (Sunrise Study). J Clin Psychiatry 76(2):181-8, 2015. | |||
